One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   North America Cardiac Monitoring Market

North America Cardiac Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Product Code : MDHC00122494
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - Abbott Laboratories
- Biotronik
- Biotelemetry
- Boston Scientific Corporation
- GE Healthcare
- Hill-Rom Holdings Inc.
- iRhythm Technologies Inc.
- Livanova Plc
- Medtronic plc
- Schiller AG

[Report Description]

The North American Cardiac Monitoring market is expected to register a CAGR of nearly 4.5% during the forecast period.

The North American cardiac monitoring market is driven by an increased burden of heart diseases, the aging population, coronary heart diseases, and technological developments in cardiac monitoring devices that reduce the chances of infection, while improving the efficiency of devices. According to the American Heart Association (AHA), cardiovascular diseases account for 17.3 million deaths per year. The Centre for Disease Control and Prevention states that about 610,000 people die due to heart diseases in the United States every year, i.e., 1 in every four deaths can be attributed to cardiovascular diseases (CVDs). The rate of diagnosis for cardiovascular diseases has been increasing since the past few years, owing to advanced monitoring capabilities of several health parameters related to heart. Such factors, in accordance with cardiovascular diseases, are driving the market’s growth.

Key Market Trends

The ECG Monitor Segment is Poised to Dominate the North American Cardiac Monitoring Market

Long-term ECG monitoring is necessary for a growing population of patients with cardiovascular diseases. With the increasing prevalence of cardiovascular diseases, the demand for the procedure increases. Generally, this procedure is possible in hospitals. However, with the introduction of wireless ECG, the doctors can monitor and diagnose the patient remotely and on time. There are two different types of ECG monitors available in the market, such as monitoring ECG systems and diagnostic ECG systems. The development of commercially advanced devices, with enabled bluetooth sensor technology and mobile app technology, is anticipated to drive the popularity of the ECG monitors segment, globally. Furthermore, technological advancements and product innovations are driving the development of ECG devices, which are likely to propel the market’s growth.

Competitive Landscape

The North American Cardiac Monitoring market is exceptionally fragmented. It consists of numerous large, medium, and small players. The multinational players account for a substantial share of the market, globally. The companies in the cardiac monitoring market are focusing on various growth strategies, in order to enhance their market presence. The growth strategies include mergers and acquisitions, partnerships, collaborations, geographical expansions, and new product launches. For instance, in October 2017, Abbott received the US Food and Drug Administration (FDA) clearance for the Confirm Rx™ Insertable Cardiac Monitor (ICM).

Additional Benefits:

  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Cardiovascular Diseases
4.2.2 Advancements in Technology
4.2.3 Demand for Home-based, Point of Care, and Remote Monitoring Cardiac Systems
4.3 Market Restraints
4.3.1 Risk of Infection Due to Implantable Monitoring Devices
4.3.2 Unfavourable Reimbursement Policies
4.4 Porter s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Device Type
5.1.1 ECG Monitor
5.1.2 Event Recorder
5.1.3 Implantable Cardiac Loop Recorder
5.1.4 Pacemaker
5.1.5 Defibrillator
5.1.6 Cardiac Resynchronization Therapy (CRT) Devices
5.1.7 Smart Wearable
5.1.8 Other Device Types
5.2 By End User
5.2.1 Hospitals and Clinics
5.2.2 Home Care Settings
5.2.3 Ambulatory Surgical Centers
5.3 Geography
5.3.1 North America United States Canada Mexico

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Biotronik
6.1.3 Biotelemetry
6.1.4 Boston Scientific Corporation
6.1.5 GE Healthcare
6.1.6 Hill-Rom Holdings Inc.
6.1.7 iRhythm Technologies Inc.
6.1.8 Livanova Plc
6.1.9 Medtronic plc
6.1.10 Schiller AG


Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports